|
Causative
Agent
Routes of Exposure
Infective Dose &
Infectivity
Incubation Period
Clinical Effects
Lethality
Transmissibility
Primary Contaminations & Methods of Dissemination
Secondary Contamination & Persistence of organism
Decontamination &
Isolation
Laboratory testing
Therapeutic Treatment
Prophylactic Treatment
Differential Diagnosis
References
Causative
Agent:
Typhus fever is a rickettsial disease caused by
the organism Rickettsia prowazekii, a Gram negative,
obligate intracellular bacterium.
Routes of Exposure:
Humans are exposed to epidemic typhus through arthropod
vectors, primarily the human body louse.
Infective Dose &
Infectivity:
The
infective dose is unknown. All people are considered
susceptible, though older adults may be more severely
affected.
Incubation Period:
The incubation period ranges from 1 to 2 weeks, but is usually
12 days.
Clinical Effects: Illness usually starts suddenly with headache,
chills, prostration, fever, and generalized body aches.
A macular eruption appears in four to seven days, initially on
the upper trunk, followed by spread to the entire body, but
usually not to the face, palms, or soles. The rash
starts as maculopapular, becomes petechial or hemorrhagic,
then develops into brownish-pigmented areas. The rash
may be more concentrated in the axillae. Changes in
mental status are common with delirium or coma. Toxemia
is usually pronounced. Myocardial and renal failure can
occur when the disease is severe. When untreated, the
fever and illness last for 2 weeks.
Lethality:
The death
rate for untreated epidemic typhus increases with age and
varies from 10% to 40%.
Transmissibility:
Typhus fever is transmitted from person to person by the body
louse, which feeds on the blood of humans. Infected lice
excrete rickettsiae in their feces and usually defecate at the
time of feeding. People are infected when they rub feces
or crush lice in the bite, superficial abrasions, or mucous
membranes. Inhalation of infective louse feces in dust
may account for some infections. Transmission has also
been associated with contact with infected flying squirrels in
the United States, their nests, or their ectoparasites.
Primary contaminations & Methods of Dissemination:
As a bioterrorism weapon, R. prowazekii
would most likely be delivered via aerosolization.
Secondary Contamination & Persistence of organism:
Direct person-to-person spread of the disease does not occur
in the absence of the vector. Rickettsia can remain
viable in a dead louse for weeks.
Decontamination &
Isolation:
-
Patients
– Standard precautions should be practiced with patients
with typhus. Louse-infected people should be treated
with pediculocides containing pyrethrins (0.16-33%),
piperonyl butoxide (2-4%), crotamiton (10%), or lindane
(1%). Several applications may be needed because lice
eggs are resistant to most insecticides.
-
Equipment,
clothing & other objects:
Washing clothes in hot water kills lice and eggs.
Insecticides dusted onto clothing has been effective in
epidemics.
Laboratory testing:
Culture isolation of R. prowazekii is rarely attempted.
The preferred serology for acute and convalescent antibodies
is the IFA test, although ELISA, microagglutination and latex
agglutination are also available. Antibody tests usually
become positive in the second week. Rickettsiae an be
detected in tissue biopsies by PCR or immunohistochemical
assays.
Therapeutic Treatment: Doxycycline is the treatment of choice for
epidemic louseborne typhus fever. Therapy should be
administered until the patient is afebrile for at least 3 days
and clinical improvement is documented; the usual duration of
therapy is 7 to 10 days. Severe disease can require a
longer course of treatment.
Despite
concerns regarding dental staining after use of a
tetracycline-class antimicrobial agent in children 8 years of
age or younger, doxycycline provides superior therapy for this
potentially life-threatening disease. In people who are
intolerant of tetracyclines, intravenous chloramphenicol or
fluoroquinolones can be considered. Fluoroquinolones are
not recommended for people younger than 18 years of age.
When faced with a seriously ill patient with possible typhus,
suitable therapy should be started without waiting for
laboratory confirmation.
Prophylactic Treatment: Vaccine is no longer available in the United
States and post-exposure chemoprophylaxis is not indicated.
Apply residual insecticide to those who are subject to risk.
Differential Diagnosis: The differential diagnoses should includes
febrile illnesses such as anthrax, dengue fever, infectious
mononucleosis, leptospirosis, malaria, meningitis,
meningococcemia, relapsing fever, Rocky Mountain spotted
fever, syphilis, toxic shock syndrome, tularemia, typhoid
fever, rubella, measles, and other rickettsial diseases.
References:
-
Chin J.
Control of Communicable Diseases Manual, Seventeenth
Edition, American Public Health Association; 2000.
-
American
Academy of Pediatrics. Epidemic Typhus. In: Pickering
LK, ed. Red Book: 2003 Report of the Committee on
Infectious Diseases. Elk Grove Village, IL: American
Academy of Pediatrics; 2003: 669-670.
-
Center for
Food Security and Public Health. Typhus Fever –
Rickettsia prowazekii, Iowa State University College of
Veterinary Medicine
For more
information call (602) 364-3289 |